MorphRx.ai
Most “AI drug discovery” stops at virtual design.
MorphRx.ai goes further.
MorphRx.ai is a self-driving lab platform where generative AI meets robotics to create, plan, and actually synthesize new medicines in real time, across any modality:
By uniting generative design with synthetic execution, MorphRx.ai makes the leap from“what could work ” to“ what can be made and tested tomorrow.”
The future of medicine isn't just designed — it's synthesized in real time.
Autonomous Therapeutic Evolution
Human goals drive an intelligent LLM/agent & generative AI. Designed candidates are synthesized, tested, and iteratively improved.
Human
Defines objective & seeds agent
LLM / Agent
Translates intent into novel candidates
Generative AI
Designs & scores molecules, PROTACs, LNPs, minoproteins, peptides, antibodies
Robotic Synthesis
Plans route, executes with validation
Wet-Lab Testing
Assays; phenotypic & structural data
MorphRx.ai Hub of Capabilities
Connecting Generative AI, Automation, and Data Integration
Ask the MorphRX.ai Agent
More than a query engine — the Agent transforms natural language into autonomous synthesis instructions , enabling robotic labs to design, build, and test LNP formulations in real time.
1,000+ Formulations
Query in Seconds
AI-Generated Insights
Our Team
MorphRx.ai is founded by scientists, engineers, and visionaries committed to accelerating therapeutic discovery.
We're actively seeking exceptional advisors to join our mission.
Parminder Mankoo, Ph.D.
Founder & CEO
Interested in Joining Our Advisory Board?
We're seeking accomplished professionals in drug discovery, biotechnology, clinical development, and commercialization to guide our mission.
Latest News
Seed Funding
MorphRx.ai raises initial funding to accelerate AI-native therapeutic design.
Partnerships
Collaborating with global labs to scale robotic discovery.
Team Expansion
Welcoming advisors and scientists to strengthen our mission.